The Helix Exchange

Helix Exchange is the first business-first podcast dedicated exclusively to the world of genomics. Our mission is simple: to make the genomics revolution understandable, usable, and actionable for finance, accounting, and business professionals. Each episode cuts through the scientific noise to deliver a clear analysis of the companies, markets, technologies, and economic forces transforming genomics into one of the most important industries of our time. From sequencing and synthetic biology to precision medicine and emerging regulation—we focus on what moves markets and drives business outcomes. If you want the real story behind the genomics economy—told with the clarity, speed, and depth of a modern financial newsroom—this is your source. All business. All genomics. All the time.

The Helix Exchange is a business podcast hosted by christinenu, with 8 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

christinenu hosts The Helix Exchange, a business show with 8 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #8

  The Business of Genomics: AI, Regulation & Point-of-Care Diagnostics Explained

  Mar 24, 202629 minS1

  <p>How do you turn genomic innovation into commercial reality? Dr. Daniel Farkas, a leader in molecular diagnostics for over three decades, joins The Helix Exchange to break down what it really takes to bring genomic technologies from lab bench to clinical practice. In this episode: The three components of every clinical test Why reimbursement can make or break a biotech company The realities of point-of-care molecular diagnostics Multi-omics and population-scale data AI’s true opportunity in genomic analysis Why healthcare technology must be dramatically better to replace existing systems Genomics is no longer just about discovery — it’s about execut...

  ListenShow Notes
• 

  Episode #6

  Redefining the Taxonomy of Human Disease | Dr. Lon Cardon

  Mar 17, 202645 minS1

  <p>In this episode of The Helix Exchange, the guest is Dr. Lon Cardon joins to discuss the opportunity that genomics has to "redefine the taxonomy of human disease". He suggests that diseases like Alzheimer's are not a single disease but rather a spectrum that might be treated in many different ways, similar to how breast cancer has 80 different histological subtypes. This idea aligns with the concept of precision medicine, which involves thinking about diseases as "collections of related diseases but with different pathways and probably different treatment paradigms". *The Jackson Laboratory (Jax)*</p> *History:* The Jackson Laboratory, founded in 1929...

  ListenShow Notes
• 

  Episode #5

  How Genomics, AI & Precision Prescribing Are Transforming Healthcare

  Mar 10, 202645 minS1

  <p>In this episode of The Helix Exchange, we sit down with Dr. Bernard Esquivel, physician, scientist, and CEO of Genesis, to explore how genomics, AI, and precision prescribing are reshaping healthcare. Dr. Esquivel explains why pharmacogenomics is not a silver bullet, how it must be integrated into real clinical workflows, and why access, adoption, and reimbursement are the true barriers to personalized medicine. From gene therapy and cancer treatment to AI-driven healthcare platforms and new business models, this conversation goes deep into what’s real, what’s hype, and what’s investable in genomics today. 🎯 Key topics covered: Precision prescribi...

  ListenShow Notes
• 

  Episode #4

  The Future of Regenerative Medicine: Dr. Iain Drummond on Organoids, Gene Therapy & Courage

  Mar 3, 202645 minS1

  <p>In this episode of The Helix Exchange, we sit down with Dr. Iain Drummond — a pioneering biologist whose work with zebrafish has transformed how we understand kidney development, organ repair, and regenerative medicine. Drummond shares how transparency in a tiny fish led to breakthroughs that could help humans one day regrow or repair organs. We discuss the future of gene therapy, organoids, lipid nanoparticle delivery, AI-driven discovery, and what it really takes to move regenerative science from the lab to real-world therapies. He also opens up about the role of courage in scientific progress, the importance of collaboration across di...

  ListenShow Notes
• 

  Episode #3

  Could Axolotls Carry The Secrets To Change Medicine Forever?

  Feb 24, 202632 minS1

  In this episode of The Helix Exchange, we dive into one of the most astonishing frontiers in regenerative biology: the axolotl, a salamander capable of regrowing limbs, organs, spinal cord, and even one-third of its brain. Our guest, Dr. Priyag Murawala, is one of the world’s leading experts on axolotl regeneration, and his research is helping uncover nature’s own blueprint for tissue repair, organ regrowth, and potential human therapies. We explore how axolotls regenerate without scarring, why fibroblasts are the “master cells” behind tissue renewal, and how these insights could drive breakthroughs in anti-fibrosis therapies, immune-guided regeneration, organ repair...

  ListenShow Notes

Recent guests on The Helix Exchange. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.